OVERVIEW
The market for immunohistochemistry is projected to reach USD 3.7 billion by 2024, rising at a CAGR of 6.46% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers and increasing medical education and demand for histopathology are expected to drive the growth of this market.
TABLE OF CONTENT
1 Global Immunohistochemistry Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Immunohistochemistry Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Immunohistochemistry Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Immunohistochemistry Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Immunohistochemistry Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Immunohistochemistry Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Immunohistochemistry Market – By Products (Market Size – & million/billion)
8.1 Antibodies
8.2 Reagents
8.3 Equipment
8.4 Kits
9 Global Immunohistochemistry Market – By Application
9.1 Diagnostics
9.2 Drug Testing
10 Global Immunohistochemistry Market – By End-User
10.1 Hospitals and Diagnostic Laboratories
10.2 Research Institutes
10.3 Other
11 Global Immunohistochemistry Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Immunohistochemistry Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Immunohistochemistry Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 F. Hoffmann-LA Roche AG
13.3 Danaher Corporation
13.4 Agilent Technologies, Inc.
13.5 Merck Millipore
13.6 Abcam PLC
13.7 Bio SB
13.8 Thermo Fisher Scientific Inc.
13.9 Bio-Rad Laboratories, Inc.
13.10 Cell Signaling Technology, Inc.
13.11 Perkinelmer, Inc.
13.12 Company 11 & more
14 Global Immunohistochemistry Market – Appendix
14.1 Sources
14.2 Abbreviations